Revenue for the third quarter of 2024 was $45.1 million, representing an increase of 11% compared to $40.8 million in the third quarter of 2023. The increase was driven by product mix shift that ...

The Nanoplasty™ MIS System is designed to deliver a reproducible 3D correction of the bunion deformity through a cosmetically appealing, hidden incision on the side of the foot and help patients get ...

Stylish shoes can add the finishing touch to an outfit and help you feel like you're putting your best foot forward. But ...

To find the best shoes for bunions, we tested 14 pairs from Skechers, Orthofeet, Vivaia, Dr. Scholl’s, and more. We looked at ...

The goal in treating ulcerative colitis is to reduce the inflammation, hopefully leading to remission. The two leading treatment options are medication and surgery. Approximately 70 percent of ...

Oct 18 (Reuters) - (This Oct. 18 story has been corrected to say that the NYSE received approval to trade options on 3, not 11 ETFs, in the headline and paragraph 1, to remove references to IBIT ...

The company said late Wednesday it will be launching futures and index options trading on its app, a move widely telegraphed for months. Both features will debut on Robinhood's app "soon," per ...

A new treatment combining ReCET and semaglutide eliminated insulin use in 86% of type 2 diabetes patients, improving natural insulin sensitivity. A new treatment combining ReCET and semaglutide could ...

Oct 16 (Reuters) - Robinhood (HOOD.O), opens new tab launched its long-awaited desktop platform and added futures and index options trading features to its mobile app on Wednesday, as the fintech ...

Until recently in the U.S., children have had two options at extreme ends of the treatment spectrum: conservative treatment or complex foot reconstruction with multiple osteotomies. "The two ...

CEO Vlad Tenev announces the launch of futures trading and index options trading in a major expansion of the platform’s offerings. Robinhood’s HOOD Summit 2024 features speakers, panel ...

The data published in The Lancet is being heralded as a big breakthrough in the treatment of cervical cancer and uses readily available chemotherapy drugs, given to patients before they receive ...